An overview of randomized clinical trials of fixed‐ratio combinations of basal insulin plus GLP ‐ 1RA (injectable therapy): Lessons for advancing therapy in people with type 2 diabetes

Documenti analoghi

• The Silver Jubilee (2025) of Insulin Glargine: Introducing the Era of Long‐Acting Insulin Analogues for Diabetes Mellitus
  di: Geremia B. Bolli, et al.
  Pubblicazione: (2026)
• Practical limitations of complex insulin therapies in type 2 diabetes: Focus on therapy simplification using fixed‐ratio combinations of basal insulin and a glucagon‐like peptide‐1 receptor agonist
  di: Luděk Horváth, et al.
  Pubblicazione: (2025)
• An overview of insulin therapy for the non‐specialist
  di: Philip D. Home
  Pubblicazione: (2025)
• Importance of targeting post‐prandial hyperglycaemia to achieve HbA1c goals in insulin glargine‐treated subphenotypes of type 2 diabetes
  di: Wolfgang Landgraf, et al.
  Pubblicazione: (2025)
• One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA
  di: Mengqing Zhang, et al.
  Pubblicazione: (2024)